LSD1 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

LSD1 shRNA Plasmid (h)

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
LSD1 shRNA Plasmid (h)

Product Specs
ItemLSD1 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-60970-SH
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
Specieshuman
NCBI Full Gene Namelysine demethylase 1A
NCBI Gene AliasesAOF2, BHC110, CPRF, KDM1, LSD1
TypeshRNA Plasmid
Quantity20 µg

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Discovery of the antitumor activities of a potent DCN1 inhibitor compound 383 targeting LSD1 in gastric cancerEuropean journal of pharmacologyFebruary 5, 2022Song Z, Gao K, Asmamaw MD, Liu YJ, Zheng YC, Shi XJ, Liu HM.

(2) Antitumor Effect of Demethylzeylasteral (T-96) on Triple-Negative Breast Cancer via LSD1-Mediate Epigenetic MechanismsAnalytical cellular pathology (Amsterdam)January 1, 2022Shen Z, Gu Y, Jiang R, Qian H, Li S, Xu L, Gu W, Zuo Y.

(3) LSD1 Facilitates Pro-Inflammatory Polarization of Macrophages by Repressing CatalaseCellsSeptember 18, 2021Sobczak M, Strachowska M, Gronkowska K, Karwaciak I, Pułaski Ł, Robaszkiewicz A.

(4) Downregulation of lysine-specific demethylase 1 enhances the sensitivity of hormone-sensitive prostate cancer cells to androgen deprivation therapyOncology lettersFebruary 1, 2021Wang M, Liu X, Chen Z, Zhang L, Weng X.

(5) Targeted DNA oxidation by LSD1-SMAD2/3 primes TGF-β1/ EMT genes for activation or repressionNucleic acids researchSeptember 18, 2020Pezone A, Taddei ML, Tramontano A, Dolcini J, Boffo FL, De Rosa M, Parri M, Stinziani S, Comito G, Porcellini A, et al.

(6) The Histone Lysine-specific Demethylase 1 Inhibitor, SP2509 Exerts Cytotoxic Effects against Renal Cancer Cells through Downregulation of Bcl-2 and Mcl-1Journal of cancer preventionJune 30, 2020Wu K, Woo SM, Kwon TK.

(7) Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockadeOncogeneJanuary 1, 2019Qin Y, Vasilatos SN, Chen L, Wu H, Cao Z, Fu Y, Huang M, Vlad AM, Lu B, Oesterreich S, et al.

(8) Lysine-specific demethylase 1 cooperates with BRAF-histone deacetylase complex 80 to enhance HIV-1 Tat-mediated transactivationVirus genesOctober 1, 2018Liu Y, Zhou D, Qi D, Feng J, Liu Z, Hu Y, Shen W, Liu C, Kong X.

(9) LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancerScientific reportsJanuary 8, 2018Boulding T, McCuaig RD, Tan A, Hardy K, Wu F, Dunn J, Kalimutho M, Sutton CR, Forwood JK, Bert AG, et al.

(10) Crosstalk between lysine methylation and phosphorylation of ATG16L1 dictates the apoptosis of hypoxia/reoxygenation-induced cardiomyocytesAutophagyJanuary 1, 2018Song H, Feng X, Zhang M, Jin X, Xu X, Wang L, Ding X, Luo Y, Lin F, Wu Q, et al.

(11) Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progressionOncogeneJanuary 5, 2017Cao C, Vasilatos SN, Bhargava R, Fine JL, Oesterreich S, Davidson NE, Huang Y.

(12) The enzymes LSD1 and Set1A cooperate with the viral protein HBx to establish an active hepatitis B viral chromatin stateScientific reportsMay 13, 2016Alarcon V, Hernández S, Rubio L, Alvarez F, Flores Y, Varas-Godoy M, De Ferrari GV, Kann M, Villanueva RA, Loyola A.

(13) Puerarin suppresses high glucose-induced MCP-1 expression via modulating histone methylation in cultured endothelial cellsLife sciencesJune 1, 2015Han P, Gao D, Zhang W, Liu S, Yang S, Li X.

(14) Crosstalk between lysine-specific demethylase 1 (LSD1) and histone deacetylases mediates antineoplastic efficacy of HDAC inhibitors in human breast cancer cellsCarcinogenesisJune 1, 2013Vasilatos SN, Katz TA, Oesterreich S, Wan Y, Davidson NE, Huang Y.

(15) The combined effect of retinoic acid and LSD1 siRNA inhibition on cell death in the human neuroblastoma cell line SH-SY5YCellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacologyJanuary 1, 2013Xu G, Xiao Y, Hu J, Xing L, Zhao O, Wu Y.

(16) Reversible methylation of promoter-bound STAT3 by histone-modifying enzymesProceedings of the National Academy of Sciences of the United States of AmericaDecember 14, 2010Yang J, Huang J, Dasgupta M, Sears N, Miyagi M, Wang B, Chance MR, Chen X, Du Y, Wang Y, et al.

Be the First to Write a Review!